Literature DB >> 2688429

Degeneration of oxidative muscle fibers in HTLV-1 tax transgenic mice.

M I Nerenberg1, C A Wiley.   

Abstract

The HTLV-1 tax gene under control of the HTLV-1 long terminal repeat (LTR) was introduced into transgenic mice. Previously tax protein expression in the muscle and peripheral nerves of three independent mouse lines was reported. Here the localization of this transgenic protein at a cellular and subcellular level is described. Tax protein was expressed in oxidative muscle fibers that developed severe progressive atrophy. It localized to the cytoplasma where it was associated with structures resembling degenerating Z bands. This pattern of muscle fiber involvement is similar to that observed in human retroviral associated myopathy. This transgenic mouse model suggests that preferential expression of the HTLV-1 viral promoter in oxidative muscle fibers may explain the productive infection of these fibers in HTLV-1 myopathy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2688429      PMCID: PMC1880495     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  40 in total

1.  Infection of human endothelial cells by human T-lymphotropic virus type I.

Authors:  D D Ho; T R Rota; M S Hirsch
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

2.  Structure of 3' terminal region of type II human T lymphotropic virus: evidence for new coding region.

Authors:  W A Haseltine; J Sodroski; R Patarca; D Briggs; D Perkins; F Wong-Staal
Journal:  Science       Date:  1984-07-27       Impact factor: 47.728

3.  "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

4.  Human T-cell leukemia virus type I: induction of syncytia and inhibition by patients' sera.

Authors:  K Nagy; P Clapham; R Cheingsong-Popov; R A Weiss
Journal:  Int J Cancer       Date:  1983-09-15       Impact factor: 7.396

5.  Point mutations close to the AUG initiator codon affect the efficiency of translation of rat preproinsulin in vivo.

Authors:  M Kozak
Journal:  Nature       Date:  1984 Mar 15-21       Impact factor: 49.962

6.  Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease.

Authors:  M Yoshida; I Miyoshi; Y Hinuma
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

7.  Natural antibodies to human retrovirus HTLV in a cluster of Japanese patients with adult T cell leukemia.

Authors:  M Robert-Guroff; Y Nakao; K Notake; Y Ito; A Sliski; R C Gallo
Journal:  Science       Date:  1982-02-19       Impact factor: 47.728

8.  Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells.

Authors:  J G Sodroski; C A Rosen; W A Haseltine
Journal:  Science       Date:  1984-07-27       Impact factor: 47.728

9.  Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera.

Authors:  Y Hinuma; K Nagata; M Hanaoka; M Nakai; T Matsumoto; K I Kinoshita; S Shirakawa; I Miyoshi
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

10.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more
  13 in total

1.  Mouse models of human T lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma.

Authors:  B Zimmerman; S Niewiesk; M D Lairmore
Journal:  Vet Pathol       Date:  2010-05-04       Impact factor: 2.221

2.  Transgenic thymocytes are refractory to transformation by the human T-cell leukemia virus type I tax gene.

Authors:  M I Nerenberg; T Minor; J Price; D N Ernst; T Shinohara; H Schwarz
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

Review 3.  Neurofibromatosis and related tumors. Natural occurrence and animal models.

Authors:  V M Riccardi; J E Womack; T Jacks
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

4.  Muscle wasting induced by HTLV-1 tax-1 protein: an in vitro and in vivo study.

Authors:  Simona Ozden; Vincent Mouly; Marie-Christine Prevost; Antoine Gessain; Gillian Butler-Browne; Pierre-Emmanuel Ceccaldi
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

5.  Adrenal medullary tumors and iris proliferation in a transgenic mouse model of neurofibromatosis.

Authors:  J E Green; A M Baird; S H Hinrichs; G K Klintworth; G Jay
Journal:  Am J Pathol       Date:  1992-06       Impact factor: 4.307

6.  Transcriptional suppression of the human T-cell leukemia virus type I long terminal repeat occurs by an unconventional interaction of a CREB factor with the R region.

Authors:  X Xu; D A Brown; I Kitajima; J Bilakovics; L W Fey; M I Nerenberg
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

Review 7.  Transgenic and knockout mice in the study of neurodegenerative diseases.

Authors:  A Aguzzi; S Brandner; S Marino; J P Steinbach
Journal:  J Mol Med (Berl)       Date:  1996-03       Impact factor: 4.599

8.  Skeletal muscle involvement in human immunodeficiency virus infection.

Authors:  D Hantaï; J G Fournier; R Vazeux; H Collin; M Baudrimont; M Fardeau
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

9.  Imaging spontaneous tumorigenesis: inflammation precedes development of peripheral NK tumors.

Authors:  Dan Rauch; Shimon Gross; John Harding; Stefan Niewiesk; Michael Lairmore; David Piwnica-Worms; Lee Ratner
Journal:  Blood       Date:  2008-10-29       Impact factor: 22.113

10.  Phorbol esters modulate the phosphorylation of human T-cell leukemia virus type I Tax.

Authors:  J D Fontes; J M Strawhecker; N D Bills; R E Lewis; S H Hinrichs
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.